Intraocular sarcoid-like reaction in patients with chronic lymphocytic leukemia
CONCLUSION: Intraocular SLRs affect fewer than 1% of patients with CLL. SLR should be on the differential diagnosis list for any CLL patient with ocular complaints, and most patients can be managed successfully with corticosteroids.PMID:38163644 | DOI:10.1016/j.jcjo.2023.11.017
Source: Canadian Journal of Ophthalmology - Category: Opthalmology Authors: Ali R Salman Wendy M Smith Timothy W Olsen Lauren A Dalvin Source Type: research
More News: Canada Health | Chronic Leukemia | Chronic Lymphocytic Leukemia | Corticosteroid Therapy | Eyes | Leukemia | Opthalmology | Paraneoplastic Syndrome | Sarcoidosis